ArticleScientific reports2025

Exploring target selectivity in designing and identifying PI3Kα inhibitors for triple negative breast cancer with fragment-based and bioisosteric replacement approach.

Debojyoti Halder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.